EUCTR2007-003376-20-IT进行中（未招募）不适用
ANTITHROMBOTIC THERAPY IN THE DIABETIC PATIENT: STUDY ON THE EFFECT ON PLATELET FUNCTIONALITY OF A GREATER DOSAGE OF ASPIRIN OR THE ASSOCIATION OF LOW DOSES OF ASPIRIN PLUS SELECTIVE INHIBITOR OF THE COX-2 - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2008年1月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-TYPE 2 DIABETES
- •-AGE 40-60 YEARS
- •-CHRONIC TREATMENT WITH ASA 75-100 MG
- •-LOW CARDIOVASCULARE RISK (LESS THAN 10% ACCORDING TO THE RISK SCORE OF ISTITUTO SUPERIORE SANITa')
- •-NO PREVIOUS CARDIOVASCULAR EVENTS
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-GASTROINTESTINAL BLEEDING
- •- RENAL FAILURE
- •- SEVERE LIVER FAILURE
- •- INTESTINAL BOWL DISEASE
- •-CONGESTIVE HEART FAILURE (NIHA 3-4)
- •- HYPERTENSION
- •- ANTICOAGULANT THERAPY
- •-THROMBOCITOSI, THROMBOCITOPENIA, POLICITEMIA
研究者
相似试验
进行中（未招募）
1 期
Antiplatelet treatment in patients with diabetes mellitus: is there a difference between aspirin, clopidogrel and prasugrel - Antiplatelet Treatment in DiabetesType 2 diabetes mellitusEUCTR2009-011907-22-GBniversity of Leeds56
已完成
2 期
Antiplatelet Treatment in DiabetesTopic: Diabetes Research NetworkSubtopic: Type 2Disease: Cardiovascular diseaseNutritional, Metabolic, EndocrineNon-insulin-dependent diabetes mellitusISRCTN79817966niversity of Leeds (UK)56
已完成
2 期
Anti-platelet therapy for prevention of diabetic nephropathydiabetic nephropathyJPRN-UMIN000007718ational Hospital Organization Headquarters150
尚未招募
3 期
Evaluating safety and efficacy of zinc ang magnesium supplements in Type 2 diabetic patients along with standard care of treatamentCTRI/2024/07/071237Dr Santra Sunny (self)
已完成
不适用
Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCIType2 Diabetes MellitusCoronary Heart DiseaseNCT04481997Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA1,000